CardioGenics Holdings Inc
CGNH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.61K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $9,605.00 |
|---|---|
| Enterprise Value | $291,291.00 |
| Earnings per Share | $-0.02 |
| Beta | 2.73 |
| Outstanding Shares | 116,716,036 |
Return
| Return on Equity | 54.90% |
|---|---|
| Return on Assets | -175.63% |
| Return on Invested Capital | 42.96% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.38 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.3 |
| Debt to Equity | -0.21 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CardioGenics Holdings Inc
4 employees
CEO: Yahia Abdul Gawad
CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international re...